Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetylcysteine for MASLD in Children and Adolescents
IRCT20220409054467N7Phase 3Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Tehran University of Medical Sciences. Started Aug 2026; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on IRCT20220409054467N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220409054467N7.